drugset / Trial / NCT01660919

Vascular and Metabolic Effects of Rosuvastatin

NCT01660919

Phase 4 Completed 160 enrolled Gachon University Gil Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators hypothesize that rosuvastatin does-dependently worsens insulin sensitivity.

Timeline

Start
2011-10
Primary completion
2013-01
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 5 mg
Comparator Rosuvastatin Small molecule 10 mg
Comparator Rosuvastatin Small molecule 20 mg

Indications